98%
921
2 minutes
20
A body of data supports the existence of core (α2-α5) dimers of BAK and BAX in the oligomeric, membrane-perturbing conformation of these essential apoptotic effector molecules. Molecular structures for these dimers have only been captured for truncated constructs encompassing the core domain alone. Here, we report a crystal structure of BAK α2-α8 dimers (i.e., minus its flexible N-terminal helix and membrane-anchoring C-terminal segment) that has been obtained through the activation of monomeric BAK with the detergent C12E8. Core dimers are evident, linked through the crystal by contacts via latch (α6-α8) domains. This crystal structure shows activated BAK dimers with the extended latch domain present. Our data provide direct evidence for the conformational change converting BAK from inert monomer to the functional dimer that destroys mitochondrial integrity. This dimer is the smallest functional unit for recombinant BAK or BAX described so far.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.molcel.2021.03.014 | DOI Listing |
Sci Adv
September 2025
Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia.
Potent and selective binders of the key proapoptotic proteins BAK and BAX have not been described. We use computational protein design to generate high affinity binders of BAK and BAX with greater than 100-fold specificity for their target. Both binders activate their targets when at low concentration, driving pore formation, but inhibit membrane permeabilization when in excess.
View Article and Find Full Text PDFJ Biotechnol
October 2025
MOE Key Laboratory & Guangdong provincial Key Laboratory of Laser Life Science, College of Biophotonics, School of Optoelectronic Science and Engineering, South China Normal University, Guangzhou 510631, China. Electronic address:
This report uses fluorescence resonance energy transfer (FRET) to explore protein-protein interactions and the relative priorities of Bcl-2 family proteins in living cells, focusing on four proteins: Mcl-1, Bak, BimL and Puma. FRET analysis of cells coexpressing CFP-Mcl-1 and YFP-Bak/Puma/BimL demonstrates the direct binding of Mcl-1 to Bak/Puma/BimL. We constructed Bak-P2A-CFP-Mcl-1, BimL-P2A-CFP-Mcl-1, and Puma-P2A-CFP-Mcl-1 plasmids to achieve the co-expression of Bak/Puma/BimL and Mcl-1.
View Article and Find Full Text PDFApoptotic cell death is regulated by the BCL-2 protein family, with clusters of BAK or BAX homodimers driving pore formation in the mitochondrial outer membrane via a poorly understood process. There is growing evidence that, in addition to BAK and BAX, lipids play an important role in pore formation. Towards a better understanding of the lipidic drivers of apoptotic pore formation in isolated mitochondria, two complementary approaches were taken.
View Article and Find Full Text PDFEMBO Rep
September 2024
Robert Bosch Center for Tumor Diseases, Stuttgart, Germany.
The Bcl-2 family controls apoptosis by direct interactions of pro- and anti-apoptotic proteins. The principle mechanism is binding of the BH3 domain of pro-apoptotic proteins to the hydrophobic groove of anti-apoptotic siblings, which is therapeutically exploited by approved BH3-mimetic anti-cancer drugs. Evidence suggests that also the transmembrane domain (TMD) of Bcl-2 proteins can mediate Bcl-2 interactions.
View Article and Find Full Text PDFFEBS Lett
June 2024
Oncode Institute and Division of Biochemistry, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Microtubules are a major component of the cytoskeleton and can accumulate a plethora of modifications. The microtubule detyrosination cycle is one of these modifications; it involves the enzymatic removal of the C-terminal tyrosine of α-tubulin on assembled microtubules and the re-ligation of tyrosine on detyrosinated tubulin dimers. This modification cycle has been implicated in cardiac disease, neuronal development, and mitotic defects.
View Article and Find Full Text PDF